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Abstract
In pluripotent stem cells, there is increasing evidence for crosstalk between post-transcriptional and transcriptional
networks, offering multifold steps at which pluripotency can be controlled. In addition to well-studied transcription factors,
chromatin modifiers and miRNAs, RNA-binding proteins are emerging as fundamental players in pluripotency regulation.
Here, we report a new role for the RNA-binding protein ESRP1 in the control of pluripotency. Knockdown of Esrp1 in mouse
embryonic stem cells induces, other than the well-documented epithelial to mesenchymal-like state, also an increase in
expression of the core transcription factors Oct4, Nanog and Sox2, thereby enhancing self-renewal of these cells. Esrp1-
depleted embryonic stem cells displayed impaired early differentiation in vitro and formed larger teratomas in vivo when
compared to control embryonic stem cells. We also show that ESRP1 binds to Oct4 and Sox2 mRNAs and decreases their
polysomal loading. ESRP1 thus acts as a physiological regulator of the finely-tuned balance between self-renewal and
commitment to a restricted developmental fate. Importantly, both mouse and human epithelial stem cells highly express
ESRP1, pinpointing the importance of this RNA-binding protein in stem cell biology.
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Introduction
Pluripotency is a unique state in which cells can self-renew
indefinitely whilst maintaining the ability to differentiate into
multiple cell types of the body. In embryonic stem (ES) cells, gene
regulatory networks comprising of the core transcription factors,
Oct4, Nanog and Sox2 as well as chromatin regulatory proteins
are involved in pluripotency maintenance [1]. High endogenous
levels of these factors are beneficial for ES cell pluripotency, but
deregulated expression of pluripotency-associated transcription
factors has been shown to change cell fate. Small increases or
decreases in Oct4 expression promote the differentiation of ES
cells into extraembryonic endoderm and mesoderm or trophec-
toderm, respectively [2,3]. Likewise, small increases in Sox2 can
trigger the differentiation of ES cells into cells that express markers
associated with a wide range of differentiated cell types [4].
Notably, there is increasing evidence for stemness and embryonic
pathways reactivating during oncogenesis [5]. It is thus extremely
important to deeper investigate the molecular mechanisms
regulating the expression levels of the pluripotency factors.
The mechanisms that control the transcription of core
pluripotency factors have been extensively studied [1,3,6,7,8]. In
addition, several lines of evidence have recently underscored the
importance of post-transcriptional regulation of gene expression in
pluripotency maintenance [9]. To this regard, the action of
microRNAs (miRNAs) as well as RNA-binding proteins (RBPs)
involved in miRNA maturation, like dicer and dcgr8 has been
investigated in detail [10,11,12,13]. More recently, the RBP Unr
(Upstream of N-ras) has been reported to post-transcriptionally
repress Gata6 expression, causing stabilization of the pluripotent
state of ES cells [14]. L1TD1, which interacts with Lin28, is also
required for human ES cells self-renewal [15]. Despite this
progress, the full contribution of RNA and of RBPs (RNA-based)
to the complex regulatory circuitry of pluripotency is probably still
underestimated, as suggested by the recent discovery that the
expression of many large intergenic non-coding (lincRNAs) has
effect on ES cell gene expression and on their differentiation state
[16,17]. In particular, the direct role of RBPs on the post-
transcriptional regulation of core pluripotency factors expression
in ES cells needs to be investigated in more depth. Genome-wide
screenings aided by computational predictions may largely assist in
this process [18].
To find new regulators of stemness/pluripotency, we analyzed
conserved co-expression network (CCN) obtained from human
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and mouse stem-cell specific cDNA microarray data [19]. This
analysis indicated the RBP Epithelial splicing regulatory protein 1
(Esrp1, also known as Rbm35a), first described as a tumor
suppressor gene mutated in approximately 50% of primary colon
tumors with microsatellite instability, as a protein possibly involved
in pluripotency [20]. We found that depletion of ESRP1 in mouse
ES cells resulted in increased self-renewal and impaired early
differentiation in vitro. Moreover, ESRP1 binds to the mRNA of
several pluripotency-related genes and decrease their polysomal
loading, hence contributing to finely tune their expression levels in
mouse ES cells. Altogether, our results indicate that ESRP1 is a
new regulator of pluripotency.
Materials and Methods
Cell Culture and Differentiation
E14 ES cells were cultured and differentiated in vitro in
embryoid bodies (EBs) as previously described [21], [22]. Briefly,
300 ES cells were cultured in EB differentiation media (see File S1
for details) in ultra-low attachment 96-well plates (Corning). Two
days later, the EBs were collected and further cultured in ultra low
attachment 6-cm dishes for the indicated times. Mouse spermato-
gonial stem cells (SSCs) were isolated from juvenile mice testis and
cultured as previously described [23]. Epcam-positive SSCs were
prepared from adult mice testis by MACS sorting [24] and
cultured on inactivated Mefs as previously described [25]. See File
S1 for details on SSC cultures.
Figure 1. Knockdown of Esrp1 in E14 ES cells using short hairpin RNA. A. qRT-PCR analysis shows depletion of Esrp1 mRNA in Esrp1-
depleted ES cells (E2) w.r.t. Scr controls; RQ is relative quantity (n = 3). B. Western blot analysis of Esrp1 expression in Scr and Esrp1-depleted ES cells.
Densitometric analysis of the Western blot is shown; A.U. is arbitrary unit (n = 3). C. Immunofluorescence analysis of ESRP1 in Scr and Esrp1-depleted
ES cells. Scale bar is 20 mm. D. Upper panel: Methylene blue staining of Scr and Esrp1-depleted ES cells plated on gelatin. Middle and lower panels:
Alkaline phosphatase (ALP) staining of Scr and Esrp1-depleted ES cells in presence and absence of LIF, respectively, showing higher number of
pluripotent colonies upon Esrp1 depletion. E. MTT assay perfomed on Scr and Esrp1-depleted ES cells at different time points shows higher
proliferation rates of the latter (n = 6). F. qRT-PCR analysis shows an increase in (i) FGFR2 IIIc/IIIb ratio and (ii) Slug, Snai1 and Vimentin in Esrp1-
depleted ES cells compared to Scr controls (n = 4). A slight decrease in E-cadherin (E-cad) was also observed. (iii) CD44 was amplified by PCR and
shows a shift from variable isoform (CD44v) to standard isoform (CD44s) upon ESRP1 depletion indicating acquisition of a ‘‘mesenchymal’’
phenotype.
doi:10.1371/journal.pone.0072300.g001
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Generation of ES Cells with Stable Knockdown of ESRP1
Screening of short hairpin (Sh) RNA for efficient knockdown of
Esrp1 in ES cells, vectors as well as lentiviruses production,
quantitative real-time polymerase chain reaction (qRT-PCR),
immunoblotting and immunofluorescence staining are described
in File S1. Primers and probes employed for PCR and qRT-PCR
are described in Table S1. Pluripotency, colony forming (alkaline
phosphatase and methylene blue staining) and cell proliferation
Figure 2. Pluripotency-related genes expression is affected by ESRP1 depletion. A. Confocal microscopy analysis of ESRP1 (red) in mouse
ES cells reveal that the protein is expressed not only in the nucleus by also in the cytoplasm of these cells. Nuclei are stained with DAPI (blue). Scale
bar is 5 mm. B. Representative Western blot analysis shows that ESRP1 is expressed mainly in the cytoplasm of mouse ES cells. As expected, Oct4 has a
main nuclear localisation. Actin and Lamin A/C were used for normalisation. C. qRT-PCR analysis of Esrp1, Oct4, Nanog, Sox2, and c-Myc mRNA in Scr
and Esrp1-depleted ES cells shows that there was a increase in their expression. RQ is relative quantity (n = 4). D. Representative Western blot analysis
of Oct4, Nanog, Sox2 and c-Myc expression in nuclear extracts from Scr and Esrp1-depleted ES cells. Densitometric analysis of the Western blots is
shown; A.U. is arbitrary unit (n = 3).
doi:10.1371/journal.pone.0072300.g002
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assays are also described in File S1. For rescue experiments, site
directed mutagenesis was perfomed on pIBX-C-FF-EmGFP-B-
ESRP1-2A (Kind gift of Pr. Russ Carstens) using QuikChange
Site-Directed Mutagenesis Kit and following the manufacturer’s
protocol (Stratagene). Primers used are described in Table S2.
pIBX-C-FF-EmGFP (Kind gift of Pr. Russ Carstens) was used as
control. Reverse transfection with lipofectamine 2000 was used for
delivery plasmid DNA into ES cells (Invitrogen). See File S1 for
further details.
Teratoma Formation
Animals were bred in the central animal facility of the
Molecular Biotechnology Center, University of Turin and were
allowed free access to chow and drinking water and maintained
under specific pathogen-free (SPF) conditions. Three hundred and
fifty thousand Scramble (Scr) control or Esrp1-depleted ES cells
were injected subcutaneously in recipient NOD-SCID-gamma
(NSG) female mice. Teratomas were allowed to grow for 3 to 5
weeks. Mice were sacrificed using carbon dioxide euthanasia,
followed by cervical dislocation to ameliorate suffering and
teratomas were taken. Formalin- fixed, paraffin-embedded
sections were stained with hematoxylin and eosin. For teratoma
Figure 3. Rescue of Esrp1-depleted cells and differentiation potential of Esrp1-depleted ES cells. A. Sequence of Esrp1 cDNA showing
ShRNA binding site (in bold and underlined) and the position of inserted mutations (red). The corresponding amino acid sequence is shown as well. B.
Alkaline phosphatase (ALP) staining of Scr and Esrp1-depleted ES cells transiently transduced either with empty vector (pEm) and with the ShRNA-
immune Esrp1-GFP cDNA (Esrp1*) (n = 3). C. qRT-PCR analysis of FGFR2 IIIc/IIIb ratio in Scr and Esrp1-depleted ES cells transiently transduced either
with empty vector (pEm) and with the ShRNA-immune Esrp1-GFP cDNA (Esrp1*) showing a reduction in this ratio upon rescue. RQ is relative quantity
(n = 3). D. qRT-PCR analysis of Esrp1, Oct4, Nanog and Sox2 mRNA in Esrp1-depleted ES cells transfected with pEm or Esrp1* expression vectors
showing reduction in the expression of these genes upon rescue. RQ is relative quantity (n = 3).
doi:10.1371/journal.pone.0072300.g003
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volume assessment, 56104 cells were injected as described above.
Tumor volume was measured with a calliper, using the formula:
K (length6width6height).
Ethics Statement
All animal procedures were carried out under animal bioethics
permit 116/92 (decreto legislativo 116/92) issued on the 11th of
September 2011 by the Bioethical committee of the University of
Turin, Italy.
RNA-immunuprecipitation
ES cells (Scr and Esrp1-depleted) were lysed and cytoplasmic
extracts used for immunoprecipitation with anti-ESRP1 antibody
or rabbit IgG and for RNA extraction as described in File S1.
Sucrose Gradient Polysome Fractionation
ES cells (Scr and Esrp1-depleted) were incubated with
cycloheximide (100 mg/ml, 15 min) and cytoplasmic lysates
(200 ml) were fractionated by ultracentrifugation through 10–
50% linear sucrose gradients and divided into 12 fractions for
analysis. Where specified, the fractions were collected using an
ISCO fractionator. RNA was extracted using Trizol and purelink
RNA kit (Invitrogen) from pooled fractions 6–12 (polysomes).
Protein was extracted using acetone/trichloroacetic acid precip-
itation. See File S1 for additional information.
Western Blotting
Protein was extracted using TENT buffer (50 mM Tris-HCl,
5 mM EDTA, 150 mM NaCl, 1% Triton-X100) and a cocktail of
protease inhibitors (Roche) and separated by SDS-PAGE.
Fractionation of nuclear and cytoplasmic proteins is described in
File S1. Antibodies used are described in Table S3. Cell culture
and protein extraction for analysis of human ESRP1 expression in
CD133+ kidney progenitor cells (KPC) [26] and kidney cancer
stem cells (KCSC) [27] were generously provided by B. Bussolati
and are described elsewhere. Densitometric analysis was per-
formed using the volume analysis option of Quantity One software
(Biorad Laboratories Inc).
Reporter Assay
ES cells were transfected with firefly luciferase reporter plasmids
(Pou5f1-luc [28], pGL3-CMV-SOX2-59UTR [29] or Basic-luc
control plasmid and control Renilla luciferase using Lipofectamine
2000 (Invitrogen). Forty-eight hours after transfection, cells were
processed using a Dual-Luciferase Reporter Assay System
(Promega) and reactions were read on a luminometer (Promega).
Figure 4. Analysis of differentiative potential of Esrp1-depleted ES cells. A. qRT-PCR analysis of Brachyury (mesoderm), Cdx2
(trophectoderm), Fgf5 (ectoderm) and FoxA1 (endoderm) mRNA in Scr and Esrp1-depleted embryoid bodies (EB) five days after the differentiation
process. RQ is relative quantity (n = 4). B. Representative qRT-PCR analysis of Oct4, Nanog and Sox2 mRNA in Scr and Esrp1-depleted EBs at different
time points. C i. Teratoma formation 4 weeks after subcutaneous injection of 350 000 Scr or Esrp1-depleted ES cells in NSG mice. Hematoxylin/eosin
staining demonstrates the presence of all three germ layers (n = 8). ii. Teratomas generated at 19 days after subcutaneous injection of 50 000 Scr and
Esrp1-depleted ES cells in NSG mice. Graph shows tumor volume measured with a calliper (n = 3).
doi:10.1371/journal.pone.0072300.g004
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Reporter firefly luciferase values were normalized to those of the
control Renilla to evaluate transfection efficiencies.
Statistical Analyses
Data are expressed as mean 6 standard deviation. Statistical
differences were determined by a 2-tailed Student’s t-test
(*P,0.05, **P,0.01, ***P,0.001). All experiments were per-
formed independently at least 3 times.
Results
Knockdown of Esrp1 Cells Results in Enhanced Self-
renewal in Mouse ES Cells
To identify new RBPs that may affect self-renewal in
pluripotent stem cells, we first selected a cluster of genes
significantly down-regulated upon the onset of differentiation in
mouse germline cell-derived pluripotent stem cells (GPSC), from
our previously generated cDNA microarray data [22,25]. Only
those genes that display an expression profile strongly similar to
key pluripotency factors in both human and mouse ES cells were
selected among them, using a previously described stem-cell
specific CCN [19]. As expected, the resulting short-list (Table S4)
was strongly enriched for proteins well known to play a critical role
in ES cell fate determination, such as SALL4, OCT4, DPPA4 and
L1TD1 [1,15,30,31]. Interestingly, this list also contained three
RNA-binding proteins, the role of which has not been previously
characterized in self-renewal of pluripotent cells: ELAV2,
RBPMS2 and ESRP1. We decided to concentrate our functional
validation on the latter, also considering that its expression has
been strongly correlated to the expression of pluripotency-
associated factors such as L1TD1, DNMT3B, LIN28 and TDGF1
by previous independent studies [15].
To examine the function of ESRP1 in mouse ES cells, we
knocked down the endogenous ESRP1 expression. ShRNA-
mediated depletion of ESRP1 by lentivirus in ES cells under
basal conditions was confirmed both at the mRNA level, by qRT-
PCR, and at the protein level, by western blotting and
immunofluorescence analyses (Figure 1A–C).
The conserved coexpression of Esrp1 with the main pluripo-
tency genes and its down-modulation during pluripotent cells
differentiation suggested that it could be a positive regulator of
pluripotency. However, in contrast with this prediction, methylene
blue and alkaline phosphatase (ALP) staining showed that Esrp1-
depleted ES cells formed undifferentiated colonies with greater
efficiency than controls, both in the presence and in the absence of
LIF. Scr ES cells differentiated in the absence of LIF and gave
reduced ALP positivity. These results suggest that a reduction in
ESRP1 may support LIF-independent ES cell propagation
(Figure 1D). Accordingly, Esrp1-depleted cells proliferated at
higher rate than Scr controls (Figure 1E). A second, independent
ShRNA against Esrp1 gave similar results (Figure S1). On
inactivated mouse embryonic fibroblasts (Mefs), Esrp1-depleted
ES cell colonies were morphologically similar to controls and
stained positive for OCT4 and NANOG (Figure S2).
As ESRP1 is well known for its involvement in maintaining an
epithelial phenotype, we analysed the EMT status of the ES cells
depleted for ESRP1 (Figure 1F). There was a statistically
significant increase in the FGFR2 IIIc/IIIb ratio in these cells
compared to Scr controls. This was accompanied by a switch from
the CD44v to CD44s isoform upon knockdown of ESRP1, as well
as an increase in Slug, Snai1 and Vimentin which are known
markers of EMT. These changes were confirmed with another
ShRNA against ESRP1 (Figure S1). On the other hand, there was
a slight but significant decrease in E-cadherin expression in the
ESRP1-depleted ES cells (Figure 1F).
Confocal microscopy analysis of E14 ES cells revealed that
ESRP1 was localized both in the nucleus and in the cytoplasm.
Figure 5. ESRP1 is expressed in spermatogonial stem cells. A.
Spermatogonial stem cells (SSCs) were characterised by qRT-PCR
analysis. RQ is relative quantity (n = 4). B. Western blot analysis shows
that ESRP1 is expressed in ES cells, in GPSCs as well as in SSCs. ES cells
and GPSCs were lysed after 30 minutes’ preplating to remove Mefs,
while SSCs were scraped off together with the Mef-feeder layer for lysis.
The primordial germ cell marker, MVH was enriched in SSCs versus the
other cell lines. Actin was used for normalisation (n = 2). 3T3 fibroblasts
were used as negative control. C. Confocal microcroscopy analysis
revealed that ESRP1 is both nuclear and cytoplasmic in the SSCs as well.
MVH staining was used as positive control. Scale bar is 5 mm.
doi:10.1371/journal.pone.0072300.g005
Role of Esrp1 in Stem Cells
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Fractionation of nuclear and cytoplasmic proteins showed that
ESRP1 was mainly located in the cytoplasm in the E14 ES cells
(Figure 2A and B), in good agreement with previous reports on
LS180 colon carcinoma cells [32]. Analysis of another ES cell line,
v6.5, confirmed these results (Figure S3). This finding, together
with the fact that ESRP1 was found to bind to c-Myc and regulate
its expression, prompted us to investigate whether ESRP1 could be
involved in the regulation of pluripotency- related genes as well.
We thus measured the levels of the core pluripotency factors,
Oct4, Nanog and Sox2 as well as the Esrp1 target c-Myc,
(Figure 2C and D) and found that they were higher, albeit
moderately, both at mRNA and protein levels with respect to Scr
controls [32].
In order to exclude the possibility of off-target effects of the
ShRNAs, rescue experiments were performed using a mutant
Esrp1. The four mutations inserted in the ShRNA binding site in
pIBX-C-FF-EmGFP-B-ESRP1-2A plasmid (Figure 3A) did not
alter ESRP1 expression when compared to a plasmid expressing
the wild-type ESRP1 (Figure S4A) [33]. Importantly, transient
introduction of this mutant plasmid into Esrp1-depleted ES cells
reverted the phenotype observed after Esrp1 depletion. In
particular, compared to cells transfected with the empty vector
only, less ALP- positive colonies formed from Esrp1-depleted ES
cells transfected with the ShRNA-immune Esrp1 (Figures 3B).
Restoration of Esrp1 expression also induced a decrease in FGFR2
IIIc/IIIb ratio and in core pluripotency genes expression
(Figure 3C and D, respectively) to a level that was comparable
to that of Scr ES cells. Similar results were obtained with ES cells
in a different genetic background (v6.5) (Figure S4B) or after
knockdown with a second ShRNA against Esrp1 (Figure S4C).
Taken together, these results indicate that Esrp1 was acting on
self-renewal by regulating the expression of pluripotency tran-
scription factors.
Depletion of Esrp1 Enhances Induced Pluripotent Stem
(iPS) Cell Colony Generation
To establish whether, besides to its role in ES cell proliferation
and self renewal, ESRP1 may also play a role in pluripotency
acquisition, its expression was analysed during the reprogramming
of primary Mefs into iPS cells as previously described [34]. In
accordance with previous studies, the expression of Esrp1 shows a
trend similar to the core pluripotency factors starting at Day 8 of
reprogramming and increasing progressively (Figure S5A) [35].
Moreover, depletion of Esrp1 in Mefs before the reprogramming
procedure resulted in increased number of iPS cell colonies as
evidenced by CDy1 and OCT4 staining compared to Scr controls
Figure 6. ESRP1 binds to pluripotency-related mRNAs. A. RNA-immunoprecipitation (RIP) was performed using an anti-ESRP1 antibody. qRT-
PCR was employed to analyse for the presence of Oct4, Nanog, Sox2, c-Myc and Lin28 mRNA bound by ESRP1. ESRP1-depleted samples were used as
negative control; RQ is relative quantity (n = 3). 18s mRNA was equally immunoprecipitated in both cell types and average threshold cycle (Ct) is
shown. B. 59UTR reporter luciferase assay of Scr and ESRP1-depleted ES cells transfected with pGL3-pCMV-59UTR-Oct4 and pGL3-pCMV-59UTR-Sox2
versus Basic pGL3 vector; A.U. is arbitrary unit (n = 6).
doi:10.1371/journal.pone.0072300.g006
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or controls not infected with ShRNA-harbouring lentiviruses (NT)
in agreement with the data on ES cells (Figure S5B and C,
respectively) [36]. EBs generated from iPS resulting from the three
conditions expressed markers of the three germ layers upon EBs
formation (Figure S6A) and formed teratomas when injected into
immuno-compromised mice (Figure S6B).
Downregulation of Esrp1 in ES Cells Results in Impaired
Early Differentiation Capacity
To assess the impact of Esrp1 depletion on the differentiation
capacity of ES cells, we generated EBs from Scr control and
Esrp1-depleted ES cells. At Day 5 of differentiation in vitro, Esrp1-
depleted ES cells showed impaired early differentiation, as
indicated by the reduced levels of mesoderm (Brachyury) and
endoderm (FoxA1) markers (Figure 4A). Ectoderm (Fgf5) marker
expression was comparable (Figure 4A). In order to exclude the
possibility that a reduction of ESRP1 expression might lead to
trophectoderm differentiation of ES cells (as previously observed
upon Oct4 and Sall4 depletion in ES cells [2,30]), we also analysed
the expression of trophectoderm (Cdx2) marker. A reduction in
Cdx2 expression was observed in Esrp1-depleted ES cells
compared to Scr ES cells (Figure 4A). Moreover, in the EBs
derived from Esrp1-depleted ES cells, the expression of pluripo-
tency-related genes remained elevated till Day 5 of differentiation
and then become comparable to Scr controls by Day 8 (Figure 4B).
In order to test whether the delay in differentiation was temporal
or absolute, in vivo teratoma assay was performed by injecting
3.56105 Esrp1-depleted cells in NOD-SCID-Gamma (NSG) mice
[37]. Resulting teratomas in 8 out of 8 mice per group comprised
all the three germ layers showing that these cells are indeed
pluripotent and that their differentiation defect is only temporal
(Figure 4C). These data establish that the depletion of Esrp1 does
not impair the multilineage differentiation potential of ES cells on
the long term. Interestingly, the same assay, performed under non-
saturating conditions (56104 ES cells) showed that Esrp1 KD ES
cell-derived teratomas grew significantly faster that those derived
from Scr control (Figure 4C). This was due to the higher
proliferation rate, as evidenced by PCNA staining, of the more
prominent neuroepithelium (asterisks and insets in Figure S7) in
teratomas generated from Esrp1-depleted ES cells compared to
Scr ES cells (Figure S7).
ESRP1 is Expressed in Epithelial Stem Cells
In order to assess the applicability of these findings to other
types of stem cells, we analysed the expression of ESRP1 in the
unipotent spermatogonial stem cells or SSCs. As expected, the
mouse SSCs express pluripotency markers like Oct4, Sox2, Klf4,
Lin28, c-Myc as well as e-cadherin, but not Nanog compared to
the pluripotent stem cells, ES and GPSCs [38,39]. ESRP1 is
expressed both at the RNA and protein levels in SSCs (Figure 5A
and B). Interestingly, ESRP1 is present both in the nucleus and the
cytoplasm of these cells, in accordance with the results obtained on
ES cells (Figure 5C and Figure 2A, respectively). Moreover,
ESRP1 is also highly expressed in CD133+ human kidney
progenitor cells, but downregulated in kidney cancer stem cells
(protein extracts kindly provided by B. Bussolati) (Figure S8)
[26,27].
Figure 7. Polysomal loading of pluripotency-related mRNAs. A i. Polysome profiles of Scr and Esrp1-depleted ES cells obtained using an ISCO-
fractionator. ii. qRT-PCR analysis shows the abundance of Oct4, Nanog, Sox2, c-Myc, Esrp1 and Lin28 mRNA in pooled polysomal fractions. 18s mRNA
was equally immunoprecipitated in both cell types and average threshold cycle (Ct) is shown. RQ is relative quantity (n = 3). B. Representative Western
blot analysis of ESRP1, RPS6 and RPL4 expression in the sucrose gradient fractions obtained from ES cells lysates under basal conditions.
doi:10.1371/journal.pone.0072300.g007
Role of Esrp1 in Stem Cells
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ESRP1 Binds to Pluripotency-related mRNAs
As a protein containing RNA-recognition motifs, ESRP1 has
been reported to associate with multiple mRNAs at their 59UTRs
in the cytoplasm and to control their turnover and/or translational
regulation [32]. To further analyse if pluripotency-related mRNAs
are also bound by ESRP1, we performed RNA-immunoprecipi-
tation with an anti-ESRP1 antibody on cytoplasmic extracts from
mouse control ES cells. In agreement with the mentioned study, c-
Myc mRNA was specifically immunoprecipitated in this assay, as
no binding to the preimmune IgG (Figure S9) or in Mefs (Table
S5) used as negative controls was detected (Figure 6A). Most
interestingly, Oct4 and Sox2 mRNAs were consistently co-
immunoprecipitated with ESRP1(Figure S9). Accordingly, when
ESRP1-depleted ES cells were used, there was statistically
significant reduction in these pluripotency-related mRNAs, but
not in Nanog or Lin28 mRNA, in the ESRP1 immunoprecipita-
tion compared to the Scr controls (Figure 6A). We further
investigated whether ESRP1 could regulate the expression of Oct4
and Sox2 mRNAs through their 59UTR regions, by analysing
translation of firefly luciferase reporter using pGL3-pCMV-
59UTR-Oct4 and pGL3-pCMV-59UTR-Sox2 versus basic
pGL3 vector. The luciferase reporter assays show that there was
a statistically significant increase in luciferase activity when ESRP1
was depleted in ES cells compared to Scr controls (Figure 6B),
Figure 8. Model for the role of ESRP1 in regulating pluripotency. Under basal conditions (upper panel), ESRP1 in the cytoplasm binds to the
59UTR of mRNAs of core pluripotency factors and negatively regulates their polysomal loading and translation. In the nucleus, the well-known role of
ESRP1 in alternative splicing ensures an epithelial-like phenotype in these cells. The ES cells are thus in a differentiation-poised state. When ESRP1 is
depleted (lower panel), the check imposed by this protein on the translation of core pluripotency factors mRNAs is removed, and there is excess
translation of the latter resulting in impaired early differentiation of these ES cells. These cells also undergo an EMT-like change.
doi:10.1371/journal.pone.0072300.g008
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confirming that ESRP1 could inhibit the expression of Oct4 and
Sox2 by binding their 59UTR regions.
Depletion of ESRP1 does not Affect the Decay Rate but
Stimulates the Polysomal Loading of Pluripotency-
related mRNAs
Since RBPs can regulate mRNA turnover, we investigated
whether ESRP1 can influence the stability of pluripotency-related
mRNAs. Actinomycin D-treated Scr and Esrp1-depleted ES cells
showed similar mRNA decay rates of Oct4, Nanog, Sox2 and c-
Myc, while as expected, there was a significant difference the
Esrp1 mRNA degradation rate in these two cell types (Figure S10).
Thus, at least in our hands, ESRP1 does not affect the analysed
pluripotency-related mRNA stability in mouse ES cells.
It is generally believed that mRNAs actively being translated are
associated with polysomes and that an increased polysome
association indicates an increase in translation efficiency [40].
Based on this assumption, to provide further evidence supporting
the inhibitory role of Esrp1 on mRNA translation, we performed
polysomal profiling [32]. Cytoplasmic extracts from Scr and
Esrp1-depleted ES cells were subjected to sucrose gradient
fractionation and total RNA was extracted from polysomal
fractions. While there was no difference in the ISCO fraction-
ator-generated polysome profile of Scr and Esrp1-depleted ES cells
(Figure 7A), the amount of core pluripotency-related factors and c-
Myc mRNAs in the pooled polysomal fractions was significantly
higher upon depletion of Esrp1 compared to controls (Figure 7A).
These results suggest that the increased protein levels of
pluripotency factors shown in Figure 2D are at least partially
due to their increased translation. On the other hand, Nanog and
Lin28 mRNA loading did not significantly differ between Scr and
Esrp1-depleted ES cells (Figure 7A). To further investigate in
which sucrose gradient fractions ESRP1 was found in ES cells
under basal conditions, we extracted proteins from the different
fractions. The results show that ESRP1 is not located in the
polysomal fractions (Figure 7B), suggesting that ESRP1 may
sequester pluripotency-related mRNAs away from the polysomes.
Taken together, our findings indicate that depletion of ESRP1 in
ES cells resulted in alteration in the level of expression of core
transcription factors and the resultant cumulative effect of these
changes affects early differentiation of these cells.
Discussion
ESRP1 has been shown to affect the mRNA translation of
several cancer-related genes, including c-Myc and Fos, through
direct binding of their 59 untranslated regions (UTRs) [20,32].
Moreover, Warzecha et al. demonstrated that ESRP1 can
promote the alternative splicing of transcripts that switch splicing
during epithelial to mesenchymal transition (EMT) [33,41,42]. Its
role in EMT and tumor progression is getting increasingly studied
[43,44,45].
In this study, we identified the RBP ESRP1 as a candidate
regulator of self renewal and pluripotency in ES cells on the basis
of its conserved co-expression with well-established pluripotency
factors. Moreover, and most importantly, we provide strong
functional evidence in support of this hypothesis, showing that
ESRP1 controls the translation of pluripotency-related mRNAs in
mouse ES cells and that its downregulation favours reprogram-
ming of differentiated fibroblasts into pluripotent cells.
The capability of ESRP1 to restrain self renewal could appear
paradoxical if its expression profile is considered. Indeed, ESRP1
is downregulated with the other pluripotency factors when both
mouse GPSC and ES cells lose pluripotency, and it is upregulated
when fibroblasts are reprogrammed into iPS cells. However, the
experiments that we performed clearly indicate that ESRP1
functionally counteracts the activity of pluripotency-related genes.
Indeed, reduced levels of Esrp1 enhances ES cells proliferation
and self renewal, as shown by the higher number of undifferen-
tiated colonies generated in vitro and by the increased size of
teratoma obtained upon injecting non-saturating amounts of cells
into immune-compromised animals compared to Scr controls. In
addition, Esrp1 knockdown increases the number of iPS cell
colonies obtained from primary differentiated fibroblasts. An
alternative explanation for these phenotypes could be that a
reduction of Esrp1 could transform pluripotent cells, a conceivable
scenario especially if considering the previous implication of
human ESRP1 as a tumor suppressor gene and in EMT [32,33].
However, our data seem to exclude this possibility. Indeed, Esrp1-
depleted cells are still capable of responding to differentiative
stimuli, albeit with a slower kinetic when compared to control
cells. Moreover, teratoma formation assays showed that these cells
are still capable of giving rise to derivatives of the three germ
layers. On the basis of these data, it seems safe to us to conclude
that, in pluripotent cells, ESRP1 is a physiological regulator of the
finely tuned balance between self renewal and commitment to a
restricted developmental fate.
The simplest explanation to reconcile the functional properties
of Esrp1 with its expression profile could be that the same
transcriptional program that sustains the expression of pluripo-
tency factors is responsible for the activation of a negative control
layer, composed of Esrp1, and possibly, by other coding or non-
coding genes. The existence of such negative fine-tuning would be
very helpful to explain how the pluripotency machinery is kept
under strict control, if considering that it is maintained in
pluripotent cells by strong positive feedback loops between the
core transcription factors [46]. An important next step to further
support this scenario will be to investigate how Esrp1 is regulated
at the transcriptional level. Interestingly, CHIP-seq data indicated
that its promoter contains binding sites for both polycomb
repressive complex (PRC) members (PRC2: EZH2 and SUZ12
and PRC1: RING1B) as well as for pluripotency-related genes
(NANOG, KLF4, TCF3), suggesting that ESRP1 level in mouse
ES cells is controlled by both pluripotency factors as well as PRC
members [46,47]. However, further studies are needed to assess
how important these factors are for the regulation of ESRP1 in ES
cells under basal conditions and in response to differentiative
stimuli.
Another important question is how does ESRP1 work at the
molecular level? The increased levels of pluripotency factors that
we detected in Esrp1-depleted cells as well as the luciferase
reporter assays, together with the previous information on ESRP1
functions, strongly suggest that it may influence the expression of
these genes by directly binding to their mRNA. Consistently, we
found that the mRNA of c-Myc as well as the mRNA of Oct4, and
Sox2 can be specifically co-immunoprecipitated with ESRP1. This
interaction does not affect the decay rate of the studied mRNAs
(Figure S7), suggesting that ESRP1 probably does not bind to the
39UTR of these mRNAs and does not affect mRNA stability [48].
The alternative possibility that ESRP1 may primarily regulate
translation was already supported by previous evidence. Indeed, it
has been shown that ectopic expression of ESRP1 results in
moderate changes in polysomal loading of a number of genes and
that it can exert a differential effect on reporter RNA translation
mediated by various 59UTRs [32]. The degree of 59UTR-
mediated translational inhibition by ESRP1 is strongly dependent
on the complexity of the secondary structure of the 59UTRs. Esrp1
was also shown to control the translation of the oncogene and
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pluripotency factor c-Myc [32]. Consistent with this hypothesis, we
found that, in Esrp1-depleted cells, the polysomal loading of
pluripotency genes is significantly increased and that ESRP1 is not
associated with polysomes. These results strongly support a
scenario in which ESRP1 reduces the levels of pluripotency
factors primarily by binding to their mRNAs and thus preventing
their association to active ribosomes. As the pluripotency
transcription factors are known to form part of a feed forward
auto-regulatory loop, even the moderate rise in their protein levels
may result in increased transcription as observed upon ESRP1
depletion in mouse ES cells (Figure 8) [46]. However, we cannot
rule out the possibility that ESRP1 may prevent translation
initiation, like for e.g., the physical binding of Esrp1 to these
mRNAs may interfere with the binding of certain elongation
initiation factors that form the initiation complex. We also cannot
exclude that ESRP1 is acting, in parallel, on alternative splicing of
other factors of the extended transcriptional network and thus
influencing the self-renewing capacity of ES cells.
Conclusion
Our results strongly support the role of ESRP1 as a
physiological regulator of pluripotency-related factors in mouse
ES cells. The expression of ESRP1 in other stem cells, of both
mouse and human origin, pinpoints the importance of this RBP in
stem cell biology.
Supporting Information
Figure S1 Two ShRNAs versus Esrp1 gave similar
results. A. Methylene blue and ALP staining of ES cells after
infection and puromycin selection in the presence of LIF. NT are
non-infected controls; ES cell colonies from Scr control and from
Esrp1-depletion with two different ShRNAs versus Esrp1 (E2 and
E4) are shown. B. Methylene blue staining of 2000 cells plated at
passage 4 on gelatin 7 days post-plating with or without LIF. ES
cell colonies from Scr control and from Esrp1-depletion with two
different ShRNAs versus Esrp1 (E2 and E4) are shown. C. MTT
assay performed 5 days after plating of Scr and Esrp1-depleted (E2
and E4) ES cells on gelatin. Bars indicate mean absorbance at
540 nm (n= 6). D. PCR analyis of CD44 isoforms (CD44
variable(v) and CD44 standard(s)) in NT and Scr ES cells versus
Esrp1-depleted (E2 and E4) ES cells. Esrp1 and Oct4 expression
was also analysed and normalised to Actin. E. qRT-PCR analysis
of FGFR2 IIIc/IIIb ratio in ES cells depleted for Esrp1 with
another ShRNA (E4) compared to Scr cells. RQ is relative
quantity.
(TIF)
Figure S2 Esrp-1-depleted ES cells are pluripotent.
Phase contrast images of Scr and Esrp1-depleted ES cell colonies
grown on inactivated Mefs. Lower panels show immunofluores-
cence staining for Oct4 and Nanog. Scale bar is 20 mm.
(TIF)
Figure S3 Analysis of Esrp1-depleted v6.5 ES cells.
Fractionation of nuclear and cytoplasmic proteins of Scr and
Esrp1-depleted ES cells were analysed for the abundance of
ESRP1. A representative Western blot is shown. Oct4 was mainly
nuclear. Blots were normalised with Actin and Lamin A/C.
(TIF)
Figure S4 Correct expression of mutated ESRP1. A.
Western blot analysis showing expression of mutated ESRP1-GFP
compared to wild type ESRP1-GFP and empty vector using anti-
GFP antibody. B. qRT-PCR analysis of the FGFR2 IIIc/IIIb ratio
upon rescue in Esrp1-depleted v6.5 ES cells. Cells were transfect-
ed either with the empty vector (pEm) or with the mutated Esrp1
(Esrp1*). RQ is relative quantity. C. Rescue experiment was
performed on ESRP1-depleted (E4) and control Scr E14 ES cells.
E4 is another ShRNA wich gave efficient reduction of ESRP1
expression. qRT-PCR analysis shows the reduction in FGFR2
IIIc/IIIb ratio upon introduction of mutated Esrp1 (Esrp1*) in E4
cells. RQ is relative quantity (n = 3).
(TIF)
Figure S5 Generation of iPS cells from Scr and Esrp1-
depleted Mefs. A. Representative qRT-PCR analysis of Esrp1,
Oct4, Nanog and Sox2 expression at different time points during
the reprogramming process. B. Representative fluorescence
images for CDy1 probe (red) of iPS colonies generated from
OSK-infected Mefs only (NT) and those double-infected either
with OSK and lentivirus expressing short hairpin versus Scr or
Esrp1. Bars show mean counts of colonies per dish. Scale bar is
100 mm. C. Oct4 staining of iPS cells generated from Esrp1-
depleted Mefs versus non-infected (NT) or Scr controls. Scale bar
is 100 mm.
(TIF)
Figure S6 Differentiative potential of iPS cells generat-
ed fromMefs infected with lentivirus harbouring ShRNA
against Scr or Esrp1. A. qRTPCR analysis of EBs generated
for the indicated time points shows that all three iPS cell types
(NT, Scr and E2) differentiate into the 3 germ layers. This graph is
representative of 2 independent analyses. B. 56105 iPS cells were
injected subcutaneously in five NOD-scid mice. Tumors were
sought after 4 weeks. Hematoxylin/eosin staining of the teratoma
sections reveal the presence of the 3 germ layers.
(TIF)
Figure S7 Histological analysis of teratomas. Hematox-
ylin/eosin (H/E) staining of sections of teratomas generated from
ESRP1-depleted ES cells compared to those derived from Scr ES
cells. Asterisks show representative neuroepithelium shown in
inset. PCNA staining shows that ESRP1-depleted teratomas have
larger proliferating neuroepithelial areas compared to Scr
teratomas. Arrows show neuroepithelium.
(TIF)
Figure S8 Analysis of ESRP1 expression in human
stem/progenitor cells. CD133+ kidney progenitor cells
(KPC) [26] express ESRP1 while kidney cancer stem cells (KCSC)
[27] do not.
(TIF)
Figure S9 RNA-immunoprecipitation in Scr ES cells.
qRT-PCR analysis of mRNA eluted from RIP in Scr ES cells
shows that there was little binding to preimmune IgG for Oct4,
Sox2 and cMyc mRNAs versus anti-ESRP1 antibody. This graph
is representative of 2 independent experiments.
(TIF)
Figure S10 mRNA decay rates of pluripotency-related
mRNAs upon Esrp1 depletion. qRT-PCR analysis of the
percentage of Oct4, Nanog, Sox2, c-Myc and Esrp1 mRNA
remaining in the ES cells after actinomycin D treatment for the
indicated time points (n = 6).
(TIF)
Table S1 Primers used for PCR and qRT-PCR, and UPL
probes used in this study.
(DOC)
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Table S2 Primers used for mutagenesis of Esrp1 cDNA
at ShRNA binding site.
(DOC)
Table S3 Antibodies used in this study.
(DOC)
Table S4 Stem cell-specific co-expression analysis re-
veals genes that are co-expressed with Oct4, Sall4,
L1TD1 and Dppa4.
(DOC)
Table S5 qRT-PCR analysis following RNA-IP with anti-
ESRP1 antibody. Results show relative quantity of mRNA of
each gene immunoprecipitating with anti-ESRP1 antibody in
primary Mefs, or using ES cells infected with lentivirus harbouring
short hairpin against Scr or GFP versus short hairpin against
Esrp1.
(DOC)
File S1 Supplementary Materials and Methods.
(DOC)
Acknowledgments
The authors thank the following persons for their contribution: Luigi
Naldini for reprogramming vectors; Russ Carstens for providing Esrp1
cDNA-containing plasmids; Robin M. Hobbs for help with spermatogonial
stem cells isolation and culture; Emilia Turco for help with mutagenesis;
Benedetta Bussolati for protein extracts from kidney progenitor cells and
kidney cancer stem cells; Rosario M. Piro and Ugo Ala for help with
bioinformatics analysis; Ornella Azzolino for assistance in Mefs prepara-
tion; Fuyuki Ishikawa and Nobuyuki Tanimura for Basic-luc and Pou5f1-
luc plasmids; Jianhai Jiang for Sox2-luc plasmid; Francesca Orso for help
in measuring luciferase activity; Elisa De Luca and Marta Gai for confocal
image acquisition; Marco Forni for advice on immunohistochemistry,
image acquisition and critical analysis of teratomas; Flavio Cristofani for
help with NSG mice; Salvatore Oliviero and his group for helpful
discussion.
Author Contributions
Conceived and designed the experiments: SF FA. Performed the
experiments: SF CB JGC RR MR LS. Analyzed the data: SF FDC ET
PPP LS FA. Contributed reagents/materials/analysis tools: CB RR PP.
Wrote the paper: SF FDC FA.
References
1. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al. (2006) The Oct4 and
Nanog transcription network regulates pluripotency in mouse embryonic stem
cells. Nat Genet 38: 431–440.
2. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4
defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet
24: 372–376.
3. Pei D (2009) Regulation of pluripotency and reprogramming by transcription
factors. J Biol Chem 284: 3365–3369.
4. Kopp JL, Ormsbee BD, Desler M, Rizzino A (2008) Small increases in the level
of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26:
903–911.
5. Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, et al. (2011) Expression
of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC
Cancer 11: 42.
6. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, et al. (2005) Transcriptional
regulation of nanog by OCT4 and SOX2. J Biol Chem 280: 24731–24737.
7. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, et al. (2009)
Regulation of stem cell pluripotency and differentiation involves a mutual
regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription
factors with polycomb repressive complexes and stem cell microRNAs. Stem
Cells Dev 18: 1093–1108.
8. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS (2009)
MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency
in human embryonic stem cells. Cell 137: 647–658.
9. Sampath P, Pritchard DK, Pabon L, Reinecke H, Schwartz SM, et al. (2008) A
hierarchical network controls protein translation during murine embryonic stem
cell self-renewal and differentiation. Cell Stem Cell 2: 448–460.
10. Heinrich EM, Dimmeler S (2012) MicroRNAs and stem cells: control of
pluripotency, reprogramming, and lineage commitment. Circ Res 110: 1014–
1022.
11. Martinez NJ, Gregory RI (2010) MicroRNA gene regulatory pathways in the
establishment and maintenance of ESC identity. Cell Stem Cell 7: 31–35.
12. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, et al. (2005)
Dicer-deficient mouse embryonic stem cells are defective in differentiation and
centromeric silencing. Genes Dev 19: 489–501.
13. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R (2007) DGCR8 is
essential for microRNA biogenesis and silencing of embryonic stem cell self-
renewal. Nat Genet 39: 380–385.
14. Elatmani H, Dormoy-Raclet V, Dubus P, Dautry F, Chazaud C, et al. (2011)
The RNA-binding protein Unr prevents mouse embryonic stem cells
differentiation toward the primitive endoderm lineage. Stem Cells 29: 1504–
1516.
15. Narva E, Rahkonen N, Emani MR, Lund R, Pursiheimo JP, et al. (2012) RNA-
binding protein L1TD1 interacts with LIN28 via RNA and is required for
human embryonic stem cell self-renewal and cancer cell proliferation. Stem Cells
30: 452–460.
16. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, et al. (2011)
lincRNAs act in the circuitry controlling pluripotency and differentiation.
Nature 477: 295–300.
17. Wright JE, Ciosk R (2013) RNA-based regulation of pluripotency. Trends Genet
29: 99–107.
18. Abujarour R, Efe J, Ding S (2010) Genome-wide gain-of-function screen
identifies novel regulators of pluripotency. Stem Cells 28: 1487–1497.
19. Piro RM, Ala U, Molineris I, Grassi E, Bracco C, et al. (2011) An atlas of tissue-
specific conserved coexpression for functional annotation and disease gene
prediction. Eur J Hum Genet 19: 1173–1180.
20. Ivanov I, Lo KC, Hawthorn L, Cowell JK, Ionov Y (2007) Identifying candidate
colon cancer tumor suppressor genes using inhibition of nonsense-mediated
mRNA decay in colon cancer cells. Oncogene 26: 2873–2884.
21. Wakayama T, Rodriguez I, Perry AC, Yanagimachi R, Mombaerts P (1999)
Mice cloned from embryonic stem cells. Proc Natl Acad Sci U S A 96: 14984–
14989.
22. Fagoonee S, Hobbs RM, De Chiara L, Cantarella D, Piro RM, et al. (2010)
Generation of functional hepatocytes from mouse germ line cell-derived
pluripotent stem cells in vitro. Stem Cells Dev 19: 1183–1194.
23. Hobbs RM, Seandel M, Falciatori I, Rafii S, Pandolfi PP (2010) Plzf regulates
germline progenitor self-renewal by opposing mTORC1. Cell 142: 468–479.
24. Ryu BY, Kubota H, Avarbock MR, Brinster RL (2005) Conservation of
spermatogonial stem cell self-renewal signaling between mouse and rat. Proc
Natl Acad Sci U S A 102: 14302–14307.
25. Hobbs RM, Fagoonee S, Papa A, Webster K, Altruda F, et al. (2012) Functional
antagonism between Sall4 and Plzf defines germline progenitors. Cell Stem Cell
10: 284–298.
26. Bussolati B, Moggio A, Collino F, Aghemo G, D’Armento G, et al. (2012)
Hypoxia modulates the undifferentiated phenotype of human renal inner
medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol
Renal Physiol 302: F116–128.
27. Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G (2008) Identification of
a tumor-initiating stem cell population in human renal carcinomas. FASEB J 22:
3696–3705.
28. Tanimura N, Saito M, Ebisuya M, Nishida E, Ishikawa F (2013) Stemness-
related factor Sall4 interacts with transcription factors Oct-3/4 and Sox2 and
occupies Oct-Sox elements in mouse embryonic stem cells. J Biol Chem 288:
5027–5038.
29. Ge Y, Zhou F, Chen H, Cui C, Liu D, et al. (2010) Sox2 is translationally
activated by eukaryotic initiation factor 4E in human glioma-initiating cells.
Biochem Biophys Res Commun 397: 711–717.
30. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, et al. (2006) Sall4 modulates
embryonic stem cell pluripotency and early embryonic development by the
transcriptional regulation of Pou5f1. Nat Cell Biol 8: 1114–1123.
31. Madan B, Madan V, Weber O, Tropel P, Blum C, et al. (2009) The
pluripotency-associated gene Dppa4 is dispensable for embryonic stem cell
identity and germ cell development but essential for embryogenesis. Mol Cell
Biol 29: 3186–3203.
32. Leontieva OV, Ionov Y (2009) RNA-binding motif protein 35A is a novel tumor
suppressor for colorectal cancer. Cell Cycle 8: 490–497.
33. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP (2009) ESRP1
and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol
Cell 33: 591–601.
34. Rizzi R, Di Pasquale E, Portararo P, Papait R, Cattaneo P, et al. (2012) Post-
natal cardiomyocytes can generate iPS cells with an enhanced capacity toward
cardiomyogenic re-differentation. Cell Death Differ 19: 1162–1174.
35. Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, et al. (2010)
Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition
in the initiation of somatic cell reprogramming. Cell Stem Cell 7: 64–77.
Role of Esrp1 in Stem Cells
PLOS ONE | www.plosone.org 12 August 2013 | Volume 8 | Issue 8 | e72300
36. Kang NY, Yun SW, Ha HH, Park SJ, Chang YT (2011) Embryonic and
induced pluripotent stem cell staining and sorting with the live-cell fluorescence
imaging probe CDy1. Nat Protoc 6: 1044–1052.
37. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, et al. (2005) Human
lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null
mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:
6477–6489.
38. Seandel M, James D, Shmelkov SV, Falciatori I, Kim J, et al. (2007) Generation
of functional multipotent adult stem cells from GPR125+ germline progenitors.
Nature 449: 346–350.
39. Tolkunova EN, Malashicheva AB, Chikhirzhina EV, Kostyleva EI, Zeng W, et
al. (2009) [E-cadherin as a novel surface marker of spermatogonial stem cells].
Tsitologiia 51: 212–218.
40. Jin J, Jing W, Lei XX, Feng C, Peng S, et al. (2011) Evidence that Lin28
stimulates translation by recruiting RNA helicase A to polysomes. Nucleic Acids
Res 39: 3724–3734.
41. Warzecha CC, Shen S, Xing Y, Carstens RP (2009) The epithelial splicing
factors ESRP1 and ESRP2 positively and negatively regulate diverse types of
alternative splicing events. RNA Biol 6: 546–562.
42. Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, et al. (2010) An ESRP-
regulated splicing programme is abrogated during the epithelial-mesenchymal
transition. EMBO J 29: 3286–3300.
43. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, et al. (2011)
CD44 splice isoform switching in human and mouse epithelium is essential for
epithelial-mesenchymal transition and breast cancer progression. J Clin Invest
121: 1064–1074.
44. Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, et al. (2012)
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of
metastatic cancer cell. Nat Commun 3: 883.
45. Di Modugno F, Iapicca P, Boudreau A, Mottolese M, Terrenato I, et al. (2012)
Splicing program of human MENA produces a previously undescribed isoform
associated with invasive, mesenchymal-like breast tumors. Proc Natl Acad
Sci U S A 109: 19280–19285.
46. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. (2008) Integration of external
signaling pathways with the core transcriptional network in embryonic stem
cells. Cell 133: 1106–1117.
47. Walker E, Chang WY, Hunkapiller J, Cagney G, Garcha K, et al. (2010)
Polycomb-like 2 associates with PRC2 and regulates transcriptional networks
during mouse embryonic stem cell self-renewal and differentiation. Cell Stem
Cell 6: 153–166.
48. Wurth L (2012) Versatility of RNA-Binding Proteins in Cancer. Comp Funct
Genomics 2012: 178525.
Role of Esrp1 in Stem Cells
PLOS ONE | www.plosone.org 13 August 2013 | Volume 8 | Issue 8 | e72300
